These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 32741234)

  • 1. Antisense oligonucleotide therapeutics in clinical trials for the treatment of inherited retinal diseases.
    Xue K; MacLaren RE
    Expert Opin Investig Drugs; 2020 Oct; 29(10):1163-1170. PubMed ID: 32741234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense Oligonucleotide-Based Splicing Correction in Individuals with Leber Congenital Amaurosis due to Compound Heterozygosity for the c.2991+1655A>G Mutation in CEP290.
    Duijkers L; van den Born LI; Neidhardt J; Bax NM; Pierrache LHM; Klevering BJ; Collin RWJ; Garanto A
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo rescue of aberrant splicing in CEP290-associated LCA by antisense oligonucleotide delivery.
    Garanto A; Chung DC; Duijkers L; Corral-Serrano JC; Messchaert M; Xiao R; Bennett J; Vandenberghe LH; Collin RW
    Hum Mol Genet; 2016 Jun; 25(12):2552-2563. PubMed ID: 27106101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Update on Gene Therapy for Inherited Retinal Dystrophy: Experience in Leber Congenital Amaurosis Clinical Trials.
    Chiu W; Lin TY; Chang YC; Isahwan-Ahmad Mulyadi Lai H; Lin SC; Ma C; Yarmishyn AA; Lin SC; Chang KJ; Chou YB; Hsu CC; Lin TC; Chen SJ; Chien Y; Yang YP; Hwang DK
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy for inherited retinal diseases: progress and possibilities.
    Hu ML; Edwards TL; O'Hare F; Hickey DG; Wang JH; Liu Z; Ayton LN
    Clin Exp Optom; 2021 May; 104(4):444-454. PubMed ID: 33689657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9-Mediated Genome Editing as a Therapeutic Approach for Leber Congenital Amaurosis 10.
    Ruan GX; Barry E; Yu D; Lukason M; Cheng SH; Scaria A
    Mol Ther; 2017 Feb; 25(2):331-341. PubMed ID: 28109959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LEBER CONGENITAL AMAUROSIS DUE TO CEP290 MUTATIONS-SEVERE VISION IMPAIRMENT WITH A HIGH UNMET MEDICAL NEED: A Review.
    Leroy BP; Birch DG; Duncan JL; Lam BL; Koenekoop RK; Porto FBO; Russell SR; Girach A
    Retina; 2021 May; 41(5):898-907. PubMed ID: 33595255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allele-specific antisense oligonucleotides for the treatment of BEST1-related dominantly inherited retinal diseases: An in vitro model.
    Karaosmanoglu B; Imren G; Utine E; Taylan Sekeroglu H; Taskiran EZ
    Exp Eye Res; 2024 Apr; 241():109833. PubMed ID: 38369231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal antisense oligonucleotide sepofarsen in Leber congenital amaurosis type 10: a phase 1b/2 trial.
    Russell SR; Drack AV; Cideciyan AV; Jacobson SG; Leroy BP; Van Cauwenbergh C; Ho AC; Dumitrescu AV; Han IC; Martin M; Pfeifer WL; Sohn EH; Walshire J; Garafalo AV; Krishnan AK; Powers CA; Sumaroka A; Roman AJ; Vanhonsebrouck E; Jones E; Nerinckx F; De Zaeytijd J; Collin RWJ; Hoyng C; Adamson P; Cheetham ME; Schwartz MR; den Hollander W; Asmus F; Platenburg G; Rodman D; Girach A
    Nat Med; 2022 May; 28(5):1014-1021. PubMed ID: 35379979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of an intravitreal antisense oligonucleotide on vision in Leber congenital amaurosis due to a photoreceptor cilium defect.
    Cideciyan AV; Jacobson SG; Drack AV; Ho AC; Charng J; Garafalo AV; Roman AJ; Sumaroka A; Han IC; Hochstedler MD; Pfeifer WL; Sohn EH; Taiel M; Schwartz MR; Biasutto P; Wit W; Cheetham ME; Adamson P; Rodman DM; Platenburg G; Tome MD; Balikova I; Nerinckx F; Zaeytijd J; Van Cauwenbergh C; Leroy BP; Russell SR
    Nat Med; 2019 Feb; 25(2):225-228. PubMed ID: 30559420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splice-Modulating Oligonucleotide QR-110 Restores CEP290 mRNA and Function in Human c.2991+1655A>G LCA10 Models.
    Dulla K; Aguila M; Lane A; Jovanovic K; Parfitt DA; Schulkens I; Chan HL; Schmidt I; Beumer W; Vorthoren L; Collin RWJ; Garanto A; Duijkers L; Brugulat-Panes A; Semo M; Vugler AA; Biasutto P; Adamson P; Cheetham ME
    Mol Ther Nucleic Acids; 2018 Sep; 12():730-740. PubMed ID: 30114557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome Surgery and Gene Therapy in Retinal Disorders.
    Chan L; Mahajan VB; Tsang SH
    Yale J Biol Med; 2017 Dec; 90(4):523-532. PubMed ID: 29259518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Augmentation for Autosomal Dominant CRX-Associated Retinopathies.
    Sun C; Chen S
    Adv Exp Med Biol; 2023; 1415():135-141. PubMed ID: 37440026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Durable vision improvement after a single treatment with antisense oligonucleotide sepofarsen: a case report.
    Cideciyan AV; Jacobson SG; Ho AC; Garafalo AV; Roman AJ; Sumaroka A; Krishnan AK; Swider M; Schwartz MR; Girach A
    Nat Med; 2021 May; 27(5):785-789. PubMed ID: 33795869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy and genome surgery in the retina.
    DiCarlo JE; Mahajan VB; Tsang SH
    J Clin Invest; 2018 Jun; 128(6):2177-2188. PubMed ID: 29856367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-Editing Strategies for Treating Human Retinal Degenerations.
    Quinn J; Musa A; Kantor A; McClements ME; Cehajic-Kapetanovic J; MacLaren RE; Xue K
    Hum Gene Ther; 2021 Mar; 32(5-6):247-259. PubMed ID: 32993386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary Retinal Dystrophy.
    Hohman TC
    Handb Exp Pharmacol; 2017; 242():337-367. PubMed ID: 28035529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10.
    Maeder ML; Stefanidakis M; Wilson CJ; Baral R; Barrera LA; Bounoutas GS; Bumcrot D; Chao H; Ciulla DM; DaSilva JA; Dass A; Dhanapal V; Fennell TJ; Friedland AE; Giannoukos G; Gloskowski SW; Glucksmann A; Gotta GM; Jayaram H; Haskett SJ; Hopkins B; Horng JE; Joshi S; Marco E; Mepani R; Reyon D; Ta T; Tabbaa DG; Samuelsson SJ; Shen S; Skor MN; Stetkiewicz P; Wang T; Yudkoff C; Myer VE; Albright CF; Jiang H
    Nat Med; 2019 Feb; 25(2):229-233. PubMed ID: 30664785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prime Editing for the Installation and Correction of Mutations Causing Inherited Retinal Disease: A Brief Methodology.
    Tsai YT; da Costa BL; Nolan ND; Caruso SM; Jenny LA; Levi SR; Tsang SH; Quinn PMJ
    Methods Mol Biol; 2023; 2560():313-331. PubMed ID: 36481907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of Gene Editing and Induced Pluripotent Stem Cells (iPSCs) in Treatment of Retinal Diseases.
    Chuang K; Fields MA; Del Priore LV
    Yale J Biol Med; 2017 Dec; 90(4):635-642. PubMed ID: 29259527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.